Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344760 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00344760: Completed Phase 4 study, sponsored by University of Maryland, Baltimore.
NCT00344760 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00344760, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
We hypothesize that using a potent antiretroviral such as Enfuvirtide during the induction phase of HAART therapy will lead to faster clearance of virus and infected cells, and lower number of minority variant HIV-1 strains.
Primary Outcome
The study is 48 weeks long and the time to viraL suppression will vary depending on the subject. Or there is the possibility that they do not supress
Interventions
- DRUG Enfuvirtide
- DRUG Efavirenz, lamivudine, and tenofovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
What the finished NCT00344760 record still lists
NCT00344760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Enfuvirtide is the first listed.
NCT00344760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00344760 about?
NCT00344760 is a clinical study titled "A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy". We hypothesize that using a potent antiretroviral such as Enfuvirtide during the induction phase of HAART therapy will lead to faster clearance of virus and infected cells, and lower number of minority variant HIV-1 strains.
What is the current status of trial NCT00344760?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2005-01. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00344760?
The interventions under investigation include: Enfuvirtide (DRUG), Efavirenz, lamivudine, and tenofovir (DRUG).
Who is sponsoring clinical trial NCT00344760?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00344760's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia